Melatonin’s Influence on Blood Cholesterol Levels

Melatonin is widely recognised for its role in regulating sleep and circadian rhythm. However, growing research suggests its physiological influence extends beyond sleep –
including potential effects on lipid metabolism, oxidative stress, and cardiometabolic health.

Recent clinical investigations have examined whether melatonin supplementation may contribute to improvements in cholesterol profiles, particularly in individuals
with metabolic disturbances or cardiovascular risk factors.

While melatonin is not traditionally viewed as a lipid-lowering intervention, evidence suggests it may influence:

• Total cholesterol levels
• Low-density lipoprotein (LDL) cholesterol
• Oxidative stress markers linked to atherosclerosis
• Inflammatory pathways involved in cardiometabolic dysfunction

These emerging findings position melatonin within a broader discussion around sleep, metabolism, and cardiovascular health.

Melatonin and Lipid Metabolism: What Clinical Research Shows

A controlled clinical trial published in Clinical Nutrition examined the impact of melatonin supplementation on lipid profiles in individuals with metabolic risk factors. Participants received melatonin daily over a defined intervention period, with lipid parameters assessed before and after supplementation.

Key Observations

• Reductions in total cholesterol levels
• Decreases in LDL cholesterol concentrations
• Improvements in certain oxidative stress biomarkers

These findings suggest that melatonin may exert modest but measurable effects on lipid regulation, particularly in populations with metabolic imbalance rather than healthy individuals.

Possible Mechanisms

Melatonin’s influence on cholesterol metabolism appears to be indirect rather than pharmacological. Proposed mechanisms include:

• Reduction of oxidative stress within vascular tissues
• Modulation of inflammatory signalling pathways
• Improved circadian alignment, which influences metabolic regulation
• Effects on hepatic lipid metabolism

Because cholesterol synthesis and metabolism follow circadian rhythms, melatonin’s regulatory role in sleep-wake cycles may partially explain its influence on lipid balance.

Melatonin, Oxidative Stress, and Cardiovascular Risk

Beyond lipid levels alone, cardiovascular health is closely tied to oxidative stress and endothelial function. Melatonin is recognised as a potent antioxidant, capable of scavenging free radicals and enhancing endogenous antioxidant enzyme activity.

Why This Matters

LDL cholesterol becomes particularly harmful when oxidised, contributing to plaque formation within arterial walls. By reducing oxidative stress, melatonin may influence not only cholesterol levels but also cholesterol behaviour within the vascular system.

• Improved antioxidant status
• Reduced lipid peroxidation markers
• Potential support for endothelial integrity

These effects suggest melatonin may play a supportive role in cardiovascular risk management when combined with lifestyle and dietary interventions.

Clinical Context: Where Melatonin Fits

It is important to emphasise that melatonin is not a substitute for established lipid-lowering therapies such as statins. However, research suggests it may provide complementary benefits, particularly in individuals with:

• Metabolic syndrome
• Sleep disruption linked to cardiometabolic dysfunction
• Elevated oxidative stress markers

The magnitude of cholesterol reduction observed in studies is modest, but biologically meaningful when viewed through the lens of inflammation, circadian biology, and metabolic integration.

Safety and Practical Considerations

Melatonin is generally well tolerated at commonly used dosages. Reported side effects are typically mild and may include:

• Daytime drowsiness
• Vivid dreams
• Mild gastrointestinal discomfort

Long-term cardiometabolic outcomes remain under investigation, and supplementation should be considered part of a broader lifestyle strategy rather than a standalone intervention.

What the Current Evidence Suggests

• Melatonin may modestly reduce total and LDL cholesterol in certain populations
• Benefits appear linked to antioxidant and circadian regulatory effects
• Improvements are more pronounced in individuals with metabolic risk factors
• Melatonin is best viewed as a complementary cardiometabolic support strategy

As research evolves, melatonin’s role may expand beyond sleep support into the wider landscape of metabolic and cardiovascular health

Scientific References

1. Melatonin Supplementation and Lipid Profile

Clinical trial examining the effects of melatonin supplementation on lipid parameters and oxidative stress markers. Clinical Nutrition. 2018.
View Abstract – Clinical Nutrition

2. Melatonin, Oxidative Stress, and Cardiometabolic Parameters

Study evaluating melatonin’s effects on cholesterol levels and oxidative stress biomarkers in individuals with metabolic risk factors.
Clinical Nutrition. 2018.
View Abstract – ScienceDirect